The effect of clumping or aggregation of red blood cells on flow has recently become of increasing interest. Unimpeded flow through the capillaries depends to a great extent upon the red cells remaining separate in the plasma. Clumping causes blockage of the blood vessels, the extent of which is governed by the rate of flow and perfusion pressure, and the relative size of the clumps and lumen of the vessel. This blocking is manifest as an increase in resistance, as in pulmonary hypertension, and can, combined with other factors such as low perfusion pressure, vasoconstriction, and a low oxygen saturation, cause widespread tissue ischaemia, especially in the brain and kidney, which are sensitive to lack of oxygen (Knisely, Eliot, and Bloch, 1945; Heimbecker and Bigelow, 1950) .
Intravascular aggregation of red cells occurs naturally in many clinical conditions, especially where tissue damage is a feature. These include traumatic shock, burns, cardiac infarcts, and during extra-corporeal circulation (Gelin, 1956 ). This can be observed in the conjunctival vessels and is reflected by a high sedimentation rate. It can also be caused in vivo and in vitro by the injection of certain substances into the blood. These include high molecular weight dextran, some radio-opaque dyes, and other large molecules such as hexadimethrine bromide ('polybrene', Abbott).
We have chosen the latter to produce experimental red cell aggregation and to study its effects on the circulation for two reasons. It is a powerful and reliable agent for causing aggregation; and it is an efficient neutralizer of heparin (Preston, Hohf, and Trippel,\ 1956 ) and as such is used at the end of cardiopulmonary by-pass. We have studied its circulatory effects in detail in order to isolate the effects of red cell aggregation that cause pulmonary hypertension.
There is no general agreement as to the effects of this drug on the circulation if given other than extremely slowly and in small amounts. A prolonged systemic hypotension has been reported (Weiss, Gilman, Catenacci, and Osterberg, 1958; Kimura, Young, Stein, and Richards, 1959; Egerton and Robinson, 1961) . On the other hand, an early rise in pulmonary artery pressure has been found by others (Rothnie and Kinmonth, 1960; Holemans and Adamis, 1962) . The latter put forward the suggestion that the changes in pressure could be due to blocking of the pulmonary vessels by red cell aggregates seen in vitro.
Other substances causing pulmonary hypertension on intravenous injection were also studied and their actions compared.
The results show how red cell aggregation can produce pulmonary hypertension due to mechanical blocking of the pulmonary vessels.' The circulatory effects described in this paper may help in the investigation of such clinical conditions as pulmonary embolism and pulmonary hypertension of the obliterative type, as well as in stressing the danger of substances likely to cause aggregation.
METHOD
IN VIVO Twenty-six mongrel dogs weighing 9 to 14 kg. were anaesthetized with intravenous sodium thiopentone. A mid-sternal thoracotomy was performed. Thin-walled P.V.C. catheters were placed in the femoral vessels, the atria, the ventricles, the main pulmonary artery, and a pulmonary vein.
Pressures were measured with Sanborn electromanometers. Zero pressure was taken as at the level of the right atrium.
Control recordings were made for three minutes before the injections, continuously during the injections, and for 10 minutes after the injections. Simultaneous electrocardiograph leads I and II were recorded during the procedure. Blood samples were collected and measured for oxygen saturation, pH, haematocrit, and sedimentation rate as described below. Samples of segments of the lung for histological examination were taken before, during, and after the injections.
Experimental pulmonary embolism due to red cell aggregation A total of 120 injections were made at various sites in the circulation. A number of these were made before the chest was opened. The standard dose of hexadimethrine used, unless otherwise stated, was 5 mg./kg. injected over a period of five seconds. This dose is not much larger than that frequently used clinically, but the speed of injection is more rapid.
The effects of the first injections in any experiment were compared with subsequent injections after neutralizing doses of heparin in equivalent amounts had been given (1:1 mg.) and all pressures were at control levels and stable.
The effects of larger or more prolonged injections of hexadimethrine were also studied, as were the modifying effects of various substances described below.
Five rabbits were anaesthetized with sodium pentobarbital ('nembutal') and similar procedures carried out.
IN VITRO The action of hexadimethrine on the red blood cells of various species was studied in vitro at different concentrations. These were compared with the effects of dextrans of different molecular weights, hypertonic solutions, heparin, and other substances. Injections of the standard dose into the circulation proximal to the lungs (veins, right atrium, right ventricle, and pulmonary artery) produced identical pressure changes which differed only in that the time lag between the injection and the onset of the pressure changes varied directly with the distance between the site of injection and the lung.
RESULTS

INTRAVENOUS INJECTIONS
As no direct method of measuring a rapidly changing flow through the lungs was available, a wide-bore polythene cannula was tied into one of the pulmonary veins, and direct timed measurements were made on the effluent. This was done in four dogs. There was a sharp drop in flow corresponding to the period of pulmonary hypertension.
There were no significant changes in the electrocardiograms apart from an occasional P pulmonale.
The primary effect (pulmonary hypertension. etc.)
was always reproducible after standard injections, whereas the delayed non-specific drop in systemic pressure was only found after the first injection and typically in intact dogs.
In six dogs injections were made into the left atrium, left ventricle, and aorta (Fig. 4) . There was no discernible rise in pulmonary artery pressure either directly or on recirculation. The circulatory effects of these injections were confined to a small drop in systemic pressure of about 25 mm. Hg which started about 8 seconds after the beginning of the injection and remained at this level for about 30 seconds. This was followed by a period of systemic hypertension before the pressure returned to normal. This overshoot was possibly due to an increase in cardiac output as the pulmonary artery pressure was also slightly raised at this time.
DRUGS MODIFYING THE CIRCULATORY EFFECTS OF
HEXADIMETHRINE
An intravenous injection of hexadimethrine in a previously heparinized dog induced the usual primary response. However, the injection of a mixture. in the same syringe, of an equivalent amount of heparin and hexadimethrine gave no circulatory response. Synchronous injection of equivalent amounts of heparin and hexadimethrine into the two femoral veins caused no pressure change but if the heparin was injected into the left atrium there was a typical response. It was clear that the local concentration of unneutralized hexadimethrine determined the pulmonary hypertensive response.
This effect was not influenced by atropine or by bilateral vagotomy. It was reproduced in isolated perfused lungs.
Intravenous injection of hexadimethrine during a steady injection of acetylcholine gave a typical primary response. Moreover, during the period of pulmonary hypertension produced by the hexadimethrine, the injection of acetylcholine did not modify the pulmonary artery pressure, as has been described in conditions of pulmonary hypertension due primarily to vasoconstriction (Harris, 1957; Rudolf. Kurland, Auld, and Paul, 1959) .
In three dogs chlorpromazine ('largactil'), 2-5 mg./ kg., was injected intravenously. A previously effective dose of intravenous serotonin, 5-10 /tg./kg., was unable to raise the pulmonary artery pressure. yet hexadimethrine produced pulmonary hypertension.
The prolonged, delayed drop in systemic pressure, which we call the secondary or non-specific effect, was abolished by antihistamine drugs; these had no effect on the primary (pulmonary hypertension) Experimental pulmonary embolism due to red cell aggregation the standard hexadimethrine injection did not have a significant effect on pressures; but the intravenous injection of three times this dose caused a similar pattern of pressure changes.
The intravenous injection of hypertonic saline (20%) caused a transient rise in pulmonary artery pressure with a fall in the systemic pressure. In contrast to the effect of hexadimethrine, in the lightly anaesthetized animal, this was accompanied by apnoea and bradycardia which could be modified by atropine. In contrast to Eliakim, Rosenberg, and Braun (1958) , we found an acute drop in pulmonary vein pressure during this pulmonary artery hypertension caused by hypertonic saline.
BLOOD SAMPLES IN VIVO AND HISTOLOGICAL SAMPLES
Arterial blood samples were collected during the control period, during the peak of pulmonary hypertension, and when pressures had returned to normal after the intravenous injection of hexadimethrine. The most striking feature was an acute drop in haematocrit during this pulmonary hypertension which returned to normal with the pressures. This drop was about 29% (12-47%) (Fig. 2) Microscopic examination of sections of lung tissue taken during the peak of pulmonary hypertension due to hexadimethrine showed the vessels of all sizes stuffed with red cells in contrast to the appearance of the lung tissue before and after (Fig. 5) . Direct microscopic observation of capillaries in the mesentery showed clumping after injections of hexadimethrine.
IN VITRO AGGREGATION OF RED CELLS The addition of hexadimethrine to blood in excess of a local concentration of 25 pug./ml. caused red cell aggregation into clumps that were clearly visible to the naked eye. Microscopically the red cells were heaped together in masses (Fig. 6) . The white cells were not affected, and this is an excellent method of separating white cells. The aggregation occurs in citrated blood. It occurs with a saline or dextrose suspension of washed red cells.
The aggregation is prevented or reversed by the addition of excess heparin (Fig.'7) . The further addition of hexadimethrine repeats the aggregation, which depends on the local concentration of free hexadimethrine. The aggregation is reflected by immediate sedimentation of the red cell clumps. This is restored to normal by an excess of heparin.
The addition of dextran to blood produced varying amounts of a finer textured aggregation. Low molecular weight dextran ('rheomacrodex') caused aggregation when large amounts were added to blood in excess of a proportion of three to one volumes.
Hypertonic saline, 20%, and protamine in large amounts (which varied considerably with the batch) also caused aggregation, which on reversal was accompanied by haemolysis. SPECIES DIFFERENCES Most species showed red cell aggregation with hexadimethrine. These included human blood and that of the dog, cat, rat, and sheep. However, the blood of rabbits did not show this and injections of hexadimethrine into this species did not cause changes in the pulmonary artery pressure.
DISCUSSION
The main direct effect of the intravenous injection of hexadimethrine in the manner described is an acute rise in the pulmonary arterial pressure accompanied by a drop in pressure distal to the lung capillaries. In certain circumstances there is a second and more prolonged fall in the systemic arterial pressure.
Pulmonary hypertension occurs when the hexadimethrine has reached the lungs, and is due mainly to the temporary blockage, or stuffing, of a great number of blood vessels by aggregates of red cells formed by this substance. Support for this hypothesis comes from the following observations:
1. The time relation of the effect to the speed and distance of injection site from the lung.
2. It is always present in species that show red cell aggregation with hexadimethrine in vitro but not where this is absent.
3. It is not affected by atropine, vagotomy, antihistamines, and antagonists to the action on pulmonary circulation of 5-OH tryptamine.
4. The effect is abolished in vivo and in vitro by adequate amounts of heparin.
5. Pressure distal to the lung capillaries drops while the pulmonary arterial pressure is raised.
6. Histological sections of lung segments show the small vessels packed with red blood cells.
7. There is at the same time an acute drop in haematocrit in the left atrial blood corresponding with the pulmonary hypertension.
The prolonged delayed drop in systemic pressure without pulmonary hypertension is possibly due to a histamine reaction. It is seen typically only after first injections and in intact animals. It is subject to tachyphylaxis, as is common with histamine-releasing drugs (Macintosh and Paton, 1949) , and is abolished or diminished by antihistamine drugs. It is probably responsible for the subjective symptoms described by Weiss et al. (1958) . These included flushing, discomfort in the chest, and dyspnoea.
The occurrence of these two circulatory changes in different circumstances may explain the contradictory findings in the literature. Weiss described the delayed drop in systemic pressure in human subjects, and this is the reaction stressed by Egerton and Robinson (1961) using intact animals. Kimura et al. (1959) Pulmonary hypertension with systemic hypotension were the primary reactions observed by Experimental pulmonary embolism due to red cell aggregation Holemans and Adamis (1962) and by Rothnie and Kinmonth (1960) .
There is considerable controversy as to the relative importance of mechanical blocking and vasoconstriction in pulmonary embolism (Aviado. 1962) .
It has been suggested that the main circulatory effects in this condition are due to the release of 5-OH tryptamine (serotonin) (Comroe, Van Lingen, Stroud, and Roncoroni, 1953; Smith and Smith, 1955) . We found that chlorpromazine, in doses large enough to abolish the circulatory effects of intravenous serotonin, had no effect on the pulmonary hypertension caused by hexadimethrine. It has also been suggested that serotonin produced red cell aggregation sufficient to cause pulmonary hypertension (Knisely, Wallace, and Addison, 1958) , but Shepherd, Donald, Linder, and Swan (1959) showed that serotonin in dextrose without any red cells could produce pulmonary hypertension. Our observations did not suggest that serotonin produced pulmonary hypertension by red cell clumping.
As pointed out above, bilateral vagotomy and atropine did not modify the pulmonary hypertension caused by hexadimethrine.
We were interested in the mechanism of the production of pulmonary hypertension by red cell emboli, and in the possible bearing of this mechanism on clinical pulmonary embolism and hypertension, where the evidence suggests that both vasoconstriction and mechanical blocking play a part (Niden and Aviado, 1956) The demonstration that the aggregation of red cells in the veins can produce acute blocking of as capacious a circulatory field as the lungs emphasizes the possible importance of this factor in relation to such conditions as pulmonary hypertension, pulmonary embolism, and other disorders of the circulation associated with poor tissue perfusion and 'sludged' blood. Hexadimethrine can produce this aggregation, and the effects of this phenomenon on other organs are being studied. It is possibly not unrelated to the clinical phenomenon of 'sludging. ' The exact mechanism of red cell aggregation is not known. However, it seems that when it occurs naturally in vivo it is the result of an imbalance in the proteins of the plasma, due either to an initiation of the complex system of coagulation due to an upset of the dynamic equilibrium of the clotting-anticlotting factors and/or to the presence of abnormally large globulins. It is probably due to a change in the net surface charge of the red cells caused either by adsorption or chelation to a large suitably charged molecule. Washed red cells are, for instance, just as strongly aggregated by hexadimethrine.
The process can be prevented or reversed by the restoration of a normal balance in nett charge. Heparin restores the aggregation caused by hexadimethrine possibly by physical combination with the molecules. Low molecular dextran, which is used to prevent aggregation, probably acts by restoring the electrostatic status quo upset by the loss of albumin molecules and the consequent preponderance of larger molecules. This aspect is reported more fully in another paper. High concentrations of low molecular dextran actually cause aggregation (above 80%). Low molecular dextran, 10-20 ml./kg., protected dogs from pulmonary hypertension due to the injection of hexadimethrine described above. The dose of the latter had to be increased threefold to get a standard response.
Other substances causing red cell aggregation have been studied and compared. These included dextran, large doses of protamine, and hypertonic solutions.
Our findings emphasize that red cell aggregation can be an important factor in impeding flow. This effect is increased by a low perfusion pressure, vasoconstriction or pre-existing increased resistance. It should be stressed that where these conditions exist, as in chronic pulmonary hypertension or after cardiopulmonary by-pass, hexadimethrine
